Stock Research for ONTX

ONTX

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ONTX Stock Chart & Research Data

The ONTX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ONTX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ONTX Due diligence Resources & Stock Charts

The ONTX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ONTX Detailed Price Forecast - CNN Money CNN View ONTX Detailed Summary - Google Finance
Yahoo View ONTX Detailed Summary - Yahoo! Finance Zacks View ONTX Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ONTX Trends & Analysis - Trade-Ideas Barrons View ONTX Major Holders - Barrons
NASDAQ View ONTX Call Transcripts - NASDAQ Seeking View ONTX Breaking News & Analysis - Seeking Alpha
Spotlight View ONTX Annual Report - CompanySpotlight.com OTC Report View ONTX OTC Short Report - OTCShortReport.com
TradeKing View ONTX Fundamentals - TradeKing Charts View ONTX SEC Filings - Bar Chart
WSJ View Historical Prices for ONTX - The WSJ Morningstar View Performance/Total Return for ONTX - Morningstar
MarketWatch View the Analyst Estimates for ONTX - MarketWatch CNBC View the Earnings History for ONTX - CNBC
StockMarketWatch View the ONTX Earnings - StockMarketWatch MacroAxis View ONTX Buy or Sell Recommendations - MacroAxis
Bullish View the ONTX Bullish Patterns - American Bulls Short Pains View ONTX Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ONTX Stock Mentions - StockTwits PennyStocks View ONTX Stock Mentions - PennyStockTweets
Twitter View ONTX Stock Mentions - Twitter Invest Hub View ONTX Investment Forum News - Investor Hub
Yahoo View ONTX Stock Mentions - Yahoo! Message Board Seeking Alpha View ONTX Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ONTX - SECform4.com Insider Cow View Insider Transactions for ONTX - Insider Cow
CNBC View ONTX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ONTX - OTC Markets
Yahoo View Insider Transactions for ONTX - Yahoo! Finance NASDAQ View Institutional Holdings for ONTX - NASDAQ


Stock Charts

FinViz View ONTX Stock Insight & Charts - FinViz.com StockCharts View ONTX Investment Charts - StockCharts.com
BarChart View ONTX Stock Overview & Charts - BarChart Trading View View ONTX User Generated Charts - Trading View




Latest Financial News for ONTX


Free Technical Research on OPKO Health and Three More Biotech Equities
Posted on Tuesday July 17, 2018

On Monday, July 16, 2018, the NASDAQ Composite and the S&P 500 edged 0.26% and 0.10% lower, respectively at the closing bell, while the Dow Jones Industrial Average stayed bullish, finishing marginally higher by 0.18%. Taking into consideration yesterday's market sentiment, WallStEquities.com assessed the following Biotechnology equities this morning: Onconova Therapeutics Inc. (NASDAQ: ONTX), Ophthotech Corp. (NASDAQ: OPHT), OPKO Health Inc. (NASDAQ: OPK), and OvaScience Inc. (NASDAQ: OVAS).


Onconova Therapeutics Announces Promotion for Steven M. Fruchtman, M.D.
Posted on Thursday June 21, 2018

Onconova Therapeutics, Inc. (ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary focus on myelodysplastic syndromes (MDS), today announced the promotion of Dr. Steven M. Fruchtman. In his new role as President, Dr. Fruchtman will have oversight over the entire product portfolio, as well as a key role in all other areas of the Company. Dr. Fruchtman will continue to report to Dr. Ramesh Kumar, co-founder and Chief Executive Officer of the Company.


Onconova Therapeutics Announces Presentation at the 23rd Congress of the European Hematology Association
Posted on Thursday June 07, 2018

Onconova Therapeutics, Inc. (ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary focus on myelodysplastic syndromes (MDS), today announced a presentation at the 23rd Congress of the European Hematology Association being held June 14-17, 2018 in Stockholm, Sweden.  Dr. Steven Fruchtman, Onconova’s Chief Medical Officer and Senior VP, Research & Development, will be attending the conference. A copy of the poster and oral presentation will be available by visiting "Scientific Presentations" in the Investors section of Onconova's website immediately following the event.


Onconova Therapeutics, Inc. to Present at the 8th Annual LD Micro Invitational
Posted on Tuesday May 29, 2018

LOS ANGELES, CA / ACCESSWIRE / May 29, 2018 / Onconova Therapeutics, Inc. (ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes (MDS), today announced that it will be presenting at the 8th Annual LD Micro Invitational on Monday, June 4th at 9:00a PDT / 12:00p EDT at the Luxe Sunset Bel Air Hotel in Los Angeles. Mr. Mark Guerin, Chief Financial Officer of Onconova, will be giving the presentation and meeting with investors. "The event is slated to be our largest Invitational to date," stated Chris Lahiji, President of LD Micro.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.